Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation. Christoph F Kollmann

Semin Immunol. 2025 Sep 23;80:101994. doi: 10.1016/j.smim.2025.101994. Online ahead of print. ABSTRACT Oncolytic virotherapy (OVT) is a novel approach to cancer treatment that utilizes viruses to infect and destroy tumor cells selectively. Beyond direct oncolysis, OVT significantly reshapes the tumor microenvironment (TME), activating the adaptive immune system to generate robust and durable anti-tumor immunity. This … Read more

Gut mucosal immune responses – Implications for celiac disease and food allergy. Valérie Abadie

Semin Immunol. 2025 Aug 30;80:101984. doi: 10.1016/j.smim.2025.101984. Online ahead of print. ABSTRACT The intestinal mucosa employs a diverse set of defense mechanisms-from mucosal barrier regulation to immunoregulatory pathways-to maintain homeostasis despite constant exposure to microbial and dietary antigens. Failure to establish immune tolerance to food antigens can lead to pathological conditions such as celiac disease … Read more

Autoimmune diabetes and targets for immunomodulation. Camillo Bechi Genzano

Semin Immunol. 2025 Aug 28;79:101983. doi: 10.1016/j.smim.2025.101983. Online ahead of print. ABSTRACT In Type 1 diabetes (T1D), pancreatic β cells are progressively lost, resulting in insulin insufficiency. Although exogenous insulin is essential for disease management, it is not a cure, and inadequate glycemic control continues to result in long-term complications. Thus, there is a need … Read more

Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights. Rachel Weissman-Tsukamoto

Semin Immunol. 2025 Aug 14;79:101981. doi: 10.1016/j.smim.2025.101981. Online ahead of print. ABSTRACT Neuropsychiatric manifestations of systemic lupus erythematosus (NPSLE) occur in more than half of patients with SLE, with symptoms including fatigue, anxiety, depression, pain, psychosis, and cognitive dysfunction. These symptoms are often present at the time of diagnosis of SLE and can be insidious. … Read more

Potential role of microbes in antigen-based food sensitivities. Alberto Caminero

Semin Immunol. 2025 Aug 7;79:101982. doi: 10.1016/j.smim.2025.101982. Online ahead of print. ABSTRACT Approximately 20 % of the global population reports adverse reactions to foods, with food allergy and celiac disease being the most well-characterized conditions. Although they involve distinct pathological mechanisms, both are recognized as antigen-driven immune disorders and potentially sharing unidentified genetic and environmental … Read more

Epigenetic mechanisms in HCC immune landscape: Therapeutic implications. Maite G Fernandez-Barrena

Semin Immunol. 2025 Jul 29;79:101980. doi: 10.1016/j.smim.2025.101980. Online ahead of print. ABSTRACT Hepatocellular carcinoma (HCC) is the most frequent primary liver tumor and is currently a major cause of cancer-related mortality worldwide. The arrival of immune checkpoint inhibitors (ICI), and their combination with anti-VEGF/VEGFR antibodies, has transformed the treatment of patients with advanced HCC. Still, … Read more

Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions. Jiajie Tu

Semin Immunol. 2025 Jul 21;79:101979. doi: 10.1016/j.smim.2025.101979. Online ahead of print. ABSTRACT Early studies on T helper (Th) 9 cells and their specific cytokine IL-9 mainly focused on the field of allergic diseases. In addition to pathological studies, IL-9 can also affect the normal development and various functions of T cells and B cells. In … Read more

Discovery and characterization of vertebrate sialoglycan-binding proteins. Liran Adler

Semin Immunol. 2025 Jul 18;79:101978. doi: 10.1016/j.smim.2025.101978. Online ahead of print. ABSTRACT All known life forms feature a dense ensemble of cell surface and extracellular glycans. In vertebrates this includes a high density of sialic acids (Sias), a family of acidic sugars typically capping glycans of cell surface or secreted glycoproteins and glycolipids. Since Sia … Read more

A framework for the rational design of oncolytic viruses: A holistic perspective considering the tumour microenvironment. Dylan Thomas

Semin Immunol. 2025 Jun 25;79:101977. doi: 10.1016/j.smim.2025.101977. Online ahead of print. ABSTRACT Oncolytic viruses have played a pioneering role in establishing immunotherapies as the next generation of anti-cancer medicines. Recent works have highlighted the impact the tumour microenvironment has on the efficacy of immunotherapies like oncolytic viruses, as well as the ability of oncolytic viruses … Read more

Local and Cell-intrinsic complement: The new player in cancer progression. M Revel

Semin Immunol. 2025 Jun 24;79:101976. doi: 10.1016/j.smim.2025.101976. Online ahead of print. ABSTRACT The complement system, a key component of innate immunity, has a paradoxical role in cancer, acting both as a tumor suppressor and a promoter. While traditionally recognized for its extracellular immune functions, recent discoveries highlight non-canonical, intracellular roles in tumor progression. These findings … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520